SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-21-001113
Filing Date
2021-11-30
Accepted
2021-11-30 08:00:12
Documents
14
Period of Report
2021-11-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm   iXBRL 8-K 27107
2 PRESS RELEASE htbx_ex99z1.htm EX-99.1 8732
6 GRAPHIC image_001.jpg GRAPHIC 269467
  Complete submission text file 0001553350-21-001113.txt   584225

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE htbx-20211130.xsd EX-101.SCH 2756
4 XBRL LABEL FILE htbx-20211130_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE htbx-20211130_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT htbx_8k_htm.xml XML 3603
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 211458318
SIC: 2834 Pharmaceutical Preparations